Journey Medical Corp (DERM)
4.10 -0.06 (-1.44%) 11:20 ET [NASDAQ]
4.10 x 500 4.23 x 100
Realtime by (Cboe BZX)
4.10 x 500 4.23 x 100
Realtime 4.17 +0.01 (+0.24%) 08:48 ET
for Mon, Jan 27th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Sales | 14,629 | 14,855 | 13,030 | 15,257 | 34,539 |
Cost of Goods | 5,285 | 6,541 | 6,816 | 6,015 | 6,429 |
Gross Profit | 9,344 | 8,314 | 6,214 | 9,242 | 28,110 |
Operating Expenses | 12,523 | 11,782 | 17,120 | 11,361 | 11,294 |
Operating Income | -2,894 | -2,927 | -10,090 | -2,104 | 17,245 |
Interest Expense | 758 | 563 | 548 | 24 | 268 |
Other Income | 1,262 | 129 | 196 | 111 | -93 |
Pre-tax Income | -2,390 | -3,361 | -10,442 | -2,017 | 16,884 |
Income Tax | 0 | N/A | N/A | 126 | 95 |
Net Income Continuous | -2,390 | -3,361 | -10,442 | -2,143 | 16,789 |
Net Income | $-2,390 | $-3,361 | $-10,442 | $-2,143 | $16,789 |
EPS Basic Total Ops | -0.12 | -0.17 | -0.53 | -0.09 | 0.91 |
EPS Basic Continuous Ops | -0.12 | -0.17 | -0.53 | -0.09 | 0.91 |
EPS Diluted Total Ops | -0.12 | -0.17 | -0.53 | 0.02 | 0.80 |
EPS Diluted Continuous Ops | -0.12 | -0.17 | -0.53 | 0.02 | 0.80 |
EPS Diluted Before Non-Recurring Items | N/A | -0.17 | -0.53 | -0.12 | 0.80 |
EBITDA(a) | $-1,970 | $-2,024 | $-9,192 | $-1,264 | $18,139 |